A disruption in federal funds has jeopardized HIV testing and outreach in the U.S. South, and researchers warn of a ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.

I am writing to draw attention to a pressing issue that continues to affect HIV-positive individuals. The inadequacy of ...